Expression	O
of	O
oestrogen	B-protein
and	I-protein
progesterone	I-protein
receptors	I-protein
by	O
mast	B-cell_type
cells	I-cell_type
alone	O
,	O
but	O
not	O
lymphocytes	B-cell_type
,	O
macrophages	B-cell_type
or	O
other	O
immune	B-cell_type
cells	I-cell_type
in	O
human	O
upper	O
airways	O
.	O

BACKGROUND	O
:	O
Nasal	O
polyposis	O
often	O
coexists	O
with	O
asthma	O
in	O
airway	O
inflammatory	O
conditions	O
characterised	O
by	O
the	O
infiltration	O
of	O
a	O
range	O
of	O
immune	B-cell_type
cells	I-cell_type
.	O

A	O
potentially	O
important	O
role	O
for	O
ovarian	O
hormones	O
has	O
been	O
implicated	O
in	O
airway	O
inflammation	O
but	O
the	O
cellular	O
target	O
for	O
such	O
action	O
is	O
not	O
known	O
.	O

METHODS	O
:	O
Expression	O
of	O
oestrogen	B-protein
receptors	I-protein
(	O
ER	B-protein
)	O
and	O
progesterone	B-protein
receptors	I-protein
(	O
PR	B-protein
)	O
was	O
examined	O
using	O
immunohistochemistry	O
in	O
formalin	O
fixed	O
nasal	O
polyp	O
tissues	O
from	O
47	O
subjects	O
.	O

The	O
cells	O
positive	O
for	O
ER	B-protein
or	O
PR	B-protein
were	O
confirmed	O
by	O
spatial	O
location	O
,	O
dual	O
immunolabelling	O
,	O
and	O
histochemical	O
staining	O
.	O

RESULTS	O
:	O
Consistent	O
with	O
the	O
known	O
features	O
of	O
nasal	O
polyps	O
,	O
CD4+	B-cell_type
(	I-cell_type
T	I-cell_type
helper/inducer	I-cell_type
)	I-cell_type
,	O
CD8+	B-cell_type
(	I-cell_type
cytotoxic/suppressor	I-cell_type
)	I-cell_type
,	O
CD68+	B-cell_type
(	O
macrophages	B-cell_type
)	O
,	O
mast	B-cell_type
cells	I-cell_type
,	O
eosinophils	B-cell_type
and	O
neutrophils	B-cell_type
were	O
all	O
clearly	O
detected	O
by	O
their	O
relevant	O
monoclonal	B-protein
antibodies	I-protein
or	O
appropriate	O
histochemical	O
staining	O
,	O
but	O
only	O
mast	B-cell_type
cells	I-cell_type
tested	O
positive	O
for	O
ER	B-protein
/PR	O
labelling	O
with	O
their	O
polyclonal	B-protein
and	I-protein
monoclonal	I-protein
antibodies	I-protein
.	O

The	O
frequencies	O
for	O
expression	O
were	O
61.7	O
%	O
for	O
ER	B-cell_type
positive	I-cell_type
and	O
59.6	O
%	O
for	O
PR	B-cell_type
positive	I-cell_type
cells	I-cell_type
.	O

The	O
expression	O
of	O
ER	B-protein
/	O
PR	B-protein
was	O
independent	O
of	O
patient	O
sex	O
and	O
age	O
but	O
was	O
highly	O
correlated	O
with	O
the	O
numbers	O
of	O
mast	B-cell_type
cells	I-cell_type
(	O
r	O
=	O
0.973	O
,	O
p	O
<	O
0.001	O
for	O
ER	B-protein
;	O
r	O
=	O
0.955	O
,	O
p	O
<	O
0.001	O
for	O
PR	B-protein
)	O
.	O

Fewer	O
than	O
5	O
%	O
of	O
mast	B-cell_type
cells	I-cell_type
were	O
found	O
to	O
be	O
negative	O
for	O
ER	B-protein
/	O
PR	B-protein
expression	O
.	O

CONCLUSIONS	O
:	O
Mast	B-cell_type
cells	I-cell_type
alone	O
,	O
but	O
not	O
lymphocytes	B-cell_type
,	O
macrophages	B-cell_type
,	O
or	O
other	O
immune	B-cell_type
cells	I-cell_type
,	O
express	O
ER	B-protein
/	O
PR	B-protein
in	O
human	O
upper	O
airways	O
.	O

Numerous	O
ER/PR	B-cell_type
positive	I-cell_type
mast	I-cell_type
cells	I-cell_type
exist	O
in	O
nasal	O
polyps	O
,	O
indicating	O
that	O
this	O
may	O
be	O
a	O
major	O
route	O
for	O
the	O
involvement	O
of	O
sex	O
hormones	O
in	O
airway	O
inflammation	O
when	O
exposed	O
to	O
the	O
higher	O
and	O
varying	O
concentration	O
of	O
oestrogen	O
and	O
progesterone	O
characteristic	O
of	O
females	O
.	O

Thorax	NULL
2001	NULL
;	NULL
56:205-211	NULL
School	NULL
of	NULL
Biomedical	NULL
Sciences	NULL
,	NULL
University	NULL
of	NULL
Ulster	NULL
,	NULL
Coleraine	NULL
BT52	NULL
18A	NULL
,	NULL
Northern	NULL
Ireland	NULL
,	NULL
UK	NULL
X	NULL
J	NULL
Zhao	NULL
G	NULL
McKerr	NULL
C	NULL
A	NULL
Higgins	NULL
B	NULL
M	NULL
Hannigan	NULL
Department	NULL
of	NULL
Otorhinolaryngology	NULL
,	NULL
Third	NULL
Teaching	NULL
Hospital	NULL
,	NULL
Norman	NULL
Bethune	NULL
University	NULL
of	NULL
Medical	NULL
Sciences	NULL
,	NULL
Changchun	NULL
130021	NULL
,	NULL
P.	NULL
R.	NULL
China	NULL
X	NULL
J	NULL
Zhao	NULL
Z	NULL
Dong	NULL
Z	NULL
Q	NULL
Yang	NULL
Histopathology	NULL
Department	NULL
,	NULL
Antrim	NULL
Area	NULL
Hospital	NULL
,	NULL
Antrim	NULL
BT41	NULL
2RL	NULL
,	NULL
Northern	NULL
Ireland	NULL
,	NULL
UK	NULL
J	NULL
Carson	NULL
Correspondence	NULL
to	NULL
:	NULL
Professor	NULL
B	NULL
M	NULL
Hannigan	NULL
bm.hannigan	NULL
@	NULL
ulst.ac.uk	NULL
Received	NULL
16	NULL
August	NULL
2000	NULL
Returned	NULL
to	NULL
authors	NULL
25	NULL
September	NULL
2000	NULL
Revised	NULL
manuscript	NULL
received	NULL
14	NULL
October	NULL
2000	NULL
Accepted	NULL
for	NULL
publication	NULL
4	NULL
December	NULL
2000	NULL
205	NULL
Expression	NULL
of	NULL
oestrogen	NULL
and	NULL
progesterone	NULL
receptors	NULL
by	NULL
mast	NULL
cells	NULL
alone	NULL
,	NULL
but	NULL
not	NULL
lymphocytes	NULL
,	NULL
macrophages	NULL
or	NULL
other	NULL
immune	NULL
cells	NULL
in	NULL
human	NULL
upper	NULL
airways	NULL
X	NULL
J	NULL
Zhao	NULL
,	NULL
G	NULL
McKerr	NULL
,	NULL
Z	NULL
Dong	NULL
,	NULL
C	NULL
A	NULL
Higgins	NULL
,	NULL
J	NULL
Carson	NULL
,	NULL
Z	NULL
Q	NULL
Yang	NULL
,	NULL
B	NULL
M	NULL
Hannigan	NULL
Abstract	NULL
Background-Nasal	NULL
polyposis	NULL
often	NULL
coexists	NULL
with	NULL
asthma	NULL
in	NULL
airway	NULL
inflammatory	NULL
conditions	NULL
characterised	NULL
by	NULL
the	NULL
infiltration	NULL
of	NULL
a	NULL
range	NULL
of	NULL
immune	NULL
cells	NULL
.	NULL

A	NULL
potentially	NULL
important	NULL
role	NULL
for	NULL
ovarian	NULL
hormones	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
airway	NULL
inflammation	NULL
but	NULL
the	NULL
cellular	NULL
target	NULL
for	NULL
such	NULL
action	NULL
is	NULL
not	NULL
known	NULL
.	NULL

Methods-Expression	NULL
of	NULL
oestrogen	NULL
receptors	NULL
(	NULL
ER	NULL
)	NULL
and	NULL
progesterone	NULL
receptors	NULL
(	NULL
PR	NULL
)	NULL
was	NULL
examined	NULL
using	NULL
immunohistochemistry	NULL
in	NULL
formalin	NULL
fixed	NULL
nasal	NULL
polyp	NULL
tissues	NULL
from	NULL
47	NULL
subjects	NULL
.	NULL

The	NULL
cells	NULL
positive	NULL
for	NULL
ER	NULL
or	NULL
PR	NULL
were	NULL
confirmed	NULL
by	NULL
spatial	NULL
location	NULL
,	NULL
dual	NULL
immunolabelling	NULL
,	NULL
and	NULL
histochemical	NULL
staining	NULL
.	NULL

Results-Consistent	NULL
with	NULL
the	NULL
known	NULL
features	NULL
of	NULL
nasal	NULL
polyps	NULL
,	NULL
CD4+	NULL
(	NULL
T	NULL
helper/	NULL
inducer	NULL
)	NULL
,	NULL
CDS8+	NULL
(	NULL
cytotoxic/supressor	NULL
)	NULL
,	NULL
CD68+	NULL
(	NULL
macrophages	NULL
)	NULL
,	NULL
mast	NULL
cells	NULL
,	NULL
eosinophils	NULL
and	NULL
neutrophils	NULL
were	NULL
all	NULL
clearly	NULL
detected	NULL
by	NULL
their	NULL
relevant	NULL
monoclonal	NULL
antibodies	NULL
or	NULL
appropriate	NULL
histochemical	NULL
staining	NULL
,	NULL
but	NULL
only	NULL
mast	NULL
cells	NULL
tested	NULL
positive	NULL
for	NULL
ER/PR	NULL
labelling	NULL
with	NULL
their	NULL
polyclonal	NULL
and	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

The	NULL
frequencies	NULL
for	NULL
expression	NULL
were	NULL
61.7	NULL
%	NULL
for	NULL
ER	NULL
positive	NULL
and	NULL
59.6	NULL
%	NULL
for	NULL
PR	NULL
positive	NULL
cells	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
ER/PR	NULL
was	NULL
independent	NULL
of	NULL
patient	NULL
sex	NULL
and	NULL
age	NULL
but	NULL
was	NULL
highly	NULL
correlated	NULL
with	NULL
the	NULL
numbers	NULL
of	NULL
mast	NULL
cells	NULL
(	NULL
r	NULL
=	NULL
0.973	NULL
,	NULL
p	NULL
<	NULL
0.001	NULL
for	NULL
ER	NULL
;	NULL
r	NULL
=	NULL
0.955	NULL
,	NULL
p	NULL
<	NULL
0.001	NULL
for	NULL
PR	NULL
)	NULL
.	NULL

Fewer	NULL
than	NULL
5	NULL
%	NULL
of	NULL
mast	NULL
cells	NULL
were	NULL
found	NULL
to	NULL
be	NULL
negative	NULL
for	NULL
ER/PR	NULL
expression	NULL
.	NULL

Conclusions-Mast	NULL
cells	NULL
alone	NULL
,	NULL
but	NULL
not	NULL
lymphocytes	NULL
,	NULL
macrophages	NULL
,	NULL
or	NULL
other	NULL
immune	NULL
cells	NULL
,	NULL
express	NULL
ER/PR	NULL
in	NULL
human	NULL
upper	NULL
airways	NULL
.	NULL

Numerous	NULL
ER/PR	NULL
positive	NULL
mast	NULL
cells	NULL
exist	NULL
in	NULL
nasal	NULL
polyps	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
may	NULL
be	NULL
a	NULL
major	NULL
route	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
sex	NULL
hormones	NULL
in	NULL
airway	NULL
inflammation	NULL
when	NULL
exposed	NULL
to	NULL
the	NULL
higher	NULL
and	NULL
varying	NULL
concentration	NULL
of	NULL
oestrogen	NULL
and	NULL
progesterone	NULL
characteristic	NULL
of	NULL
fe-males	NULL
.	NULL

(	NULL
Thorax	NULL
2001	NULL
;	NULL
56:205-211	NULL
)	NULL
Keywords	NULL
:	NULL
nasal	NULL
polyposis	NULL
;	NULL
mast	NULL
cell	NULL
;	NULL
oestrogen	NULL
receptor	NULL
;	NULL
progesterone	NULL
receptor	NULL
Nasal	NULL
polyposis	NULL
and	NULL
asthma	NULL
are	NULL
inflammatory	NULL
diseases	NULL
of	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
airways	NULL
,	NULL
respectively	NULL
.	NULL

Both	NULL
have	NULL
strikingly	NULL
similar	NULL
pathologies	NULL
and	NULL
can	NULL
coexist	NULL
within	NULL
the	NULL
same	NULL
www	NULL
.	NULL

thoraxjnl.com	NULL
patient	NULL
.	NULL

The	NULL
inflammatory	NULL
basis	NULL
for	NULL
asthma	NULL
is	NULL
well	NULL
established	NULL
as	NULL
being	NULL
due	NULL
to	NULL
microvascula-ture	NULL
constrictions	NULL
causing	NULL
resultant	NULL
oedema	NULL
and	NULL
reduced	NULL
respiratory	NULL
function	NULL
.	NULL
'	NULL

``	NULL
Likewise	NULL
,	NULL
nasal	NULL
polyps	NULL
are	NULL
characterised	NULL
by	NULL
infiltration	NULL
of	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
inflammatory	NULL
cells	NULL
including	NULL
mast	NULL
cells	NULL
,	NULL
eosinophils	NULL
,	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
macrophages	NULL
.	NULL
``	NULL

Current	NULL
literature	NULL
suggests	NULL
that	NULL
both	NULL
age	NULL
and	NULL
oscillations	NULL
of	NULL
sex	NULL
hormone	NULL
levels	NULL
may	NULL
exacerbate	NULL
the	NULL
clinical	NULL
symptoms	NULL
of	NULL
asthma	NULL
.	NULL
``	NULL

''	NULL
Women	NULL
constitute	NULL
more	NULL
than	NULL
70	NULL
%	NULL
of	NULL
all	NULL
adult	NULL
hospital	NULL
admissions	NULL
for	NULL
asthma	NULL
.	NULL
``	NULL

``	NULL
Sudden	NULL
death	NULL
from	NULL
premenstrual	NULL
asthma	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
two	NULL
sisters	NULL
.	NULL
``	NULL

Previous	NULL
work	NULL
has	NULL
shown	NULL
an	NULL
accelerating	NULL
effect	NULL
of	NULL
exogenous	NULL
oestrogens	NULL
on	NULL
the	NULL
development	NULL
of	NULL
induced	NULL
hypersensitivity	NULL
within	NULL
an	NULL
animal	NULL
model	NULL
,	NULL
``	NULL
although	NULL
the	NULL
target	NULL
cells	NULL
and	NULL
underlying	NULL
mechanism	NULL
for	NULL
the	NULL
sex	NULL
hormone	NULL
effect	NULL
remain	NULL
unclear	NULL
.	NULL

There	NULL
have	NULL
been	NULL
only	NULL
limited	NULL
studies	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
sex	NULL
hormones	NULL
in	NULL
airways	NULL
.	NULL

In	NULL
the	NULL
lung	NULL
,	NULL
oestradiol	NULL
administration	NULL
increased	NULL
B	NULL
receptor	NULL
density	NULL
which	NULL
was	NULL
restored	NULL
to	NULL
control	NULL
values	NULL
by	NULL
progesterone	NULL
``	NULL
;	NULL
however	NULL
,	NULL
withdrawal	NULL
of	NULL
progesterone	NULL
may	NULL
be	NULL
associated	NULL
with	NULL
decreased	NULL
smooth	NULL
muscle	NULL
relaxation	NULL
.	NULL
``	NULL

Such	NULL
data	NULL
are	NULL
conflicting	NULL
and	NULL
fail	NULL
to	NULL
resolve	NULL
important	NULL
issues	NULL
such	NULL
as	NULL
possible	NULL
receptor	NULL
involvement	NULL
and	NULL
order	NULL
of	NULL
action	NULL
.	NULL

It	NULL
would	NULL
appear	NULL
that	NULL
no	NULL
study	NULL
has	NULL
been	NULL
carried	NULL
out	NULL
to	NULL
demonstrate	NULL
the	NULL
presence	NULL
of	NULL
sex	NULL
hormone	NULL
receptors	NULL
within	NULL
airways	NULL
.	NULL

This	NULL
,	NULL
despite	NULL
evidence	NULL
from	NULL
studies	NULL
of	NULL
other	NULL
organs	NULL
showing	NULL
that	NULL
sex	NULL
hormone	NULL
exposure	NULL
and	NULL
antagonistic	NULL
blockade	NULL
can	NULL
regulate	NULL
peritoneal	NULL
mast	NULL
cell	NULL
release	NULL
of	NULL
histamine	NULL
``	NULL
and	NULL
its	NULL
inhibition	NULL
within	NULL
peripheral	NULL
basophils	NULL
``	NULL
in	NULL
a	NULL
dose	NULL
dependent	NULL
manner	NULL
.	NULL

However	NULL
,	NULL
expression	NULL
of	NULL
oestrogen	NULL
receptors	NULL
within	NULL
bladder	NULL
mast	NULL
cells	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
immunohistochemical	NULL
analysis	NULL
.	NULL
``	NULL

In	NULL
contrast	NULL
,	NULL
earlier	NULL
studies	NULL
reported	NULL
specific	NULL
oestrogen	NULL
binding	NULL
sites	NULL
,	NULL
using	NULL
whole	NULL
cell	NULL
assays	NULL
or	NULL
dextran	NULL
coated	NULL
charcoal	NULL
adsorption	NULL
(	NULL
DCC	NULL
)	NULL
method	NULL
,	NULL
on	NULL
human	NULL
peripheral	NULL
T	NULL
suppressor/cytotoxic	NULL
subsets	NULL
``	NULL
and	NULL
on	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
.	NULL
``	NULL

These	NULL
earlier	NULL
reports	NULL
still	NULL
dominate	NULL
studies	NULL
of	NULL
sex	NULL
hormone	NULL
related	NULL
diseases	NULL
``	NULL
*	NULL
where	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
immune	NULL
system	NULL
and	NULL
plasma	NULL
oestrogen/progesterone	NULL
may	NULL
predispose	NULL
women	NULL
to	NULL
the	NULL
higher	NULL
incidence	NULL
of	NULL
a	NULL
range	NULL
of	NULL
inflammatory	NULL
,	NULL
allergic	NULL
,	NULL
and	NULL
autoimmune	NULL
dis-eases	NULL
.	NULL

With	NULL
the	NULL
current	NULL
availability	NULL
of	NULL
both	NULL
monoclonal	NULL
and	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
oestrogen	NULL
receptors	NULL
(	NULL
ER	NULL
)	NULL
and	NULL
progesterone	NULL
receptors	NULL
(	NULL
PR	NULL
)	NULL
,	NULL
together	NULL
with	NULL
stringent	NULL
206	NULL
immunohistochemical	NULL
techniques	NULL
,	NULL
it	NULL
should	NULL
now	NULL
be	NULL
possible	NULL
to	NULL
detect	NULL
and	NULL
resolve	NULL
sites	NULL
for	NULL
sex	NULL
hormone	NULL
receptors	NULL
in	NULL
the	NULL
upper	NULL
airways	NULL
.	NULL

The	NULL
aims	NULL
of	NULL
this	NULL
present	NULL
study	NULL
are	NULL
threefold	NULL
:	NULL
(	NULL
1	NULL
)	NULL
to	NULL
use	NULL
immunohistochemistry	NULL
to	NULL
identify	NULL
sites	NULL
for	NULL
sex	NULL
hormone	NULL
receptors	NULL
within	NULL
nasal	NULL
polyp	NULL
tissue	NULL
;	NULL
(	NULL
2	NULL
)	NULL
to	NULL
define	NULL
which	NULL
cell	NULL
types	NULL
express	NULL
such	NULL
receptors	NULL
;	NULL
and	NULL
(	NULL
3	NULL
)	NULL
to	NULL
use	NULL
high	NULL
affinity	NULL
antibodies	NULL
to	NULL
assess	NULL
any	NULL
gross	NULL
sex	NULL
difference	NULL
within	NULL
a	NULL
defined	NULL
population	NULL
.	NULL

Methods	NULL
Nasal	NULL
polyps	NULL
were	NULL
obtained	NULL
by	NULL
consent	NULL
from	NULL
47	NULL
patients	NULL
(	NULL
20	NULL
men	NULL
)	NULL
of	NULL
mean	NULL
age	NULL
45	NULL
years	NULL
(	NULL
range	NULL
12-76	NULL
)	NULL
who	NULL
underwent	NULL
elective	NULL
surgery	NULL
for	NULL
nasal	NULL
obstruction	NULL
at	NULL
the	NULL
Department	NULL
of	NULL
Otorhinolaryngology	NULL
,	NULL
Second	NULL
Teaching	NULL
Hospital	NULL
,	NULL
Norman	NULL
Bethune	NULL
University	NULL
,	NULL
Changchun	NULL
,	NULL
China	NULL
.	NULL

All	NULL
patients	NULL
were	NULL
non-smokers	NULL
and	NULL
had	NULL
taken	NULL
neither	NULL
steroids	NULL
nor	NULL
antibiotics	NULL
during	NULL
the	NULL
month	NULL
before	NULL
surgery	NULL
.	NULL

Continued	NULL
samples	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
Department	NULL
of	NULL
Histopathol-ogy	NULL
,	NULL
Antrim	NULL
Area	NULL
Hospital	NULL
,	NULL
Northern	NULL
Ireland	NULL
.	NULL

All	NULL
specimens	NULL
were	NULL
fixed	NULL
in	NULL
10	NULL
%	NULL
neutral	NULL
buffered	NULL
formalin	NULL
(	NULL
1.5	NULL
hours	NULL
)	NULL
,	NULL
washed	NULL
in	NULL
buffer	NULL
,	NULL
and	NULL
processed	NULL
for	NULL
wax	NULL
embedded	NULL
histological	NULL
examination	NULL
.	NULL

Individual	NULL
wax	NULL
sections	NULL
(	NULL
5	NULL
um	NULL
thick	NULL
)	NULL
were	NULL
adhered	NULL
to	NULL
3-aminopropyltrieth-oxylilane	NULL
coated	NULL
(	NULL
APES	NULL
)	NULL
microscope	NULL
slides	NULL
and	NULL
allowed	NULL
to	NULL
air	NULL
dry	NULL
.	NULL

IMMUNOHISTOCHEMISTRY	NULL
AND	NULL
TOLUIDINE	NULL
BLUE	NULL
STAINING	NULL
The	NULL
polyclonal	NULL
and	NULL
monoclonal	NULL
antibodies	NULL
used	NULL
in	NULL
this	NULL
study	NULL
are	NULL
listed	NULL
in	NULL
table	NULL
1	NULL
.	NULL

Before	NULL
staining	NULL
,	NULL
sections	NULL
were	NULL
treated	NULL
with	NULL
protease	NULL
K	NULL
(	NULL
Sigma	NULL
,	NULL
Poole	NULL
,	NULL
UK	NULL
)	NULL
(	NULL
0.1	NULL
%	NULL
aqueous	NULL
solution	NULL
containing	NULL
0.1	NULL
%	NULL
CaCl	NULL
,	NULL
)	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
37°C	NULL
,	NULL
followed	NULL
by	NULL
blockade	NULL
of	NULL
endogenous	NULL
peroxidase	NULL
activity	NULL
in	NULL
3	NULL
%	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
20	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
)	NULL
.	NULL

Sections	NULL
were	NULL
incubated	NULL
with	NULL
primary	NULL
antibodies	NULL
in	NULL
appropriate	NULL
dilu-tions	NULL
(	NULL
see	NULL
table	NULL
1	NULL
)	NULL
overnight	NULL
at	NULL
room	NULL
tempera-ture	NULL
.	NULL

Antigens	NULL
were	NULL
visualised	NULL
using	NULL
avidin-biotin	NULL
conjugates	NULL
(	NULL
Vectastain	NULL
Elite	NULL
Universal	NULL
ABC	NULL
kit	NULL
,	NULL
Vector	NULL
Laboratories	NULL
,	NULL
Peterborough	NULL
,	NULL
UK	NULL
)	NULL
directed	NULL
against	NULL
either	NULL
rabbit	NULL
or	NULL
mouse	NULL
immunoglobulins	NULL
and	NULL
ultimately	NULL
linked	NULL
to	NULL
the	NULL
insoluble	NULL
blue/black	NULL
chromogen	NULL
diaminoben-zadine	NULL
(	NULL
DAB	NULL
)	NULL
.	NULL

Tissue	NULL
histology	NULL
was	NULL
contrasted	NULL
by	NULL
staining	NULL
with	NULL
haematoxylin	NULL
or	NULL
haematoxylin/	NULL
eosin	NULL
.	NULL

Permanent	NULL
samples	NULL
were	NULL
mounted	NULL
in	NULL
Histomount	NULL
(	NULL
Raymond	NULL
A	NULL
Lamb	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Human	NULL
breast	NULL
tumour	NULL
tissue	NULL
was	NULL
used	NULL
as	NULL
positive	NULL
tissue	NULL
control	NULL
.	NULL

Immuno	NULL
controls	NULL
consisted	NULL
of	NULL
non-immunised	NULL
rabbit	NULL
IgG	NULL
or	NULL
mouse	NULL
IgG	NULL
or	NULL
PBS	NULL
instead	NULL
of	NULL
primary	NULL
antibody	NULL
.	NULL

Pre-absorption	NULL
of	NULL
Table	NULL
1	NULL
-	NULL
Polyclonal	NULL
and	NULL
monoclonal	NULL
antibodies	NULL
used	NULL
in	NULL
the	NULL
study	NULL
Zhao	NULL
,	NULL
McKerr	NULL
,	NULL
Zhen	NULL
,	NULL
et	NULL
al	NULL
hormone	NULL
receptors	NULL
was	NULL
omitted	NULL
in	NULL
favour	NULL
of	NULL
current	NULL
control	NULL
methodologies	NULL
suggested	NULL
by	NULL
Burry	NULL
.	NULL
``	NULL

Sequential	NULL
sections	NULL
were	NULL
stained	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
mast	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
0.2	NULL
%	NULL
toluidine	NULL
blue	NULL
in	NULL
60	NULL
%	NULL
ethyl	NULL
ether	NULL
(	NULL
absolute	NULL
alcohol	NULL
60	NULL
ml	NULL
,	NULL
ether	NULL
40	NULL
ml	NULL
)	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

Sections	NULL
were	NULL
subsequently	NULL
dehydrated	NULL
and	NULL
mounted	NULL
.	NULL

DUAL	NULL
LABELLING	NULL
Randomly	NULL
chosen	NULL
wax	NULL
sections	NULL
were	NULL
incubated	NULL
with	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
ER	NULL
or	NULL
PR	NULL
at	NULL
room	NULL
temperature	NULL
overnight	NULL
and	NULL
detected	NULL
by	NULL
indirect	NULL
immuno-Texas	NULL
Red	NULL
(	NULL
Amer-sham	NULL
International	NULL
plc	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

After	NULL
buffer	NULL
rinses	NULL
(	NULL
20	NULL
minutes	NULL
in	NULL
the	NULL
dark	NULL
)	NULL
a	NULL
second	NULL
primary	NULL
antibody	NULL
incubation	NULL
(	NULL
mouse	NULL
antibodies	NULL
against	NULL
one	NULL
of	NULL
the	NULL
immune	NULL
subpopulation	NULL
markers	NULL
;	NULL
table	NULL
1	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
(	NULL
1	NULL
hour	NULL
,	NULL
37°C	NULL
)	NULL
before	NULL
detection	NULL
with	NULL
fluo-rescein	NULL
linked	NULL
horse	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
40	NULL
minutes	NULL
,	NULL
room	NULL
temperature	NULL
,	NULL
1:100	NULL
diluted	NULL
TBS	NULL
,	NULL
Amersham	NULL
International	NULL
plc	NULL
)	NULL
.	NULL

When	NULL
monoclonal	NULL
antibodies	NULL
for	NULL
ER	NULL
were	NULL
used	NULL
,	NULL
sections	NULL
were	NULL
first	NULL
indirectly	NULL
labelled	NULL
for	NULL
high	NULL
affinity	NULL
monoclonal	NULL
reactivity	NULL
against	NULL
one	NULL
of	NULL
the	NULL
immune	NULL
subpopulation	NULL
markers	NULL
(	NULL
see	NULL
table	NULL
1	NULL
)	NULL
with	NULL
Texas	NULL
Red	NULL
or	NULL
,	NULL
for	NULL
immune	NULL
cell	NULL
morphol-ogy	NULL
,	NULL
with	NULL
DAB	NULL
.	NULL

After	NULL
rinses	NULL
and	NULL
an	NULL
additional	NULL
blockage	NULL
with	NULL
normal	NULL
horse	NULL
serum	NULL
(	NULL
20	NULL
minutes	NULL
,	NULL
room	NULL
temperature	NULL
)	NULL
,	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
(	NULL
AER311	NULL
for	NULL
ER	NULL
)	NULL
incubation	NULL
was	NULL
carried	NULL
out	NULL
(	NULL
1	NULL
hour	NULL
,	NULL
37°C	NULL
)	NULL
before	NULL
detection	NULL
with	NULL
fluorescence	NULL
linked	NULL
horse	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
40	NULL
minutes	NULL
,	NULL
room	NULL
temperature	NULL
,	NULL
1:100	NULL
diluted	NULL
TBS	NULL
)	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
mounted	NULL
in	NULL
Citifluor	NULL
AFl	NULL
(	NULL
Agar	NULL
Scientific	NULL
Ltd	NULL
,	NULL
Cam-bridge	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
stored	NULL
in	NULL
the	NULL
dark	NULL
at	NULL
4°C	NULL
until	NULL
they	NULL
could	NULL
be	NULL
analysed	NULL
.	NULL

Immunofluorescent	NULL
and	NULL
bright	NULL
field	NULL
results	NULL
were	NULL
read	NULL
using	NULL
a	NULL
Nikon	NULL
Optiphot	NULL
II	NULL
Microscope	NULL
equipped	NULL
with	NULL
an	NULL
epi-fluorescent	NULL
mercury	NULL
lamp	NULL
source	NULL
.	NULL

Images	NULL
were	NULL
captured	NULL
with	NULL
image	NULL
analysis	NULL
software	NULL
(	NULL
Image-dok	NULL
II	NULL
;	NULL
Kinetic	NULL
Imaging	NULL
Ltd	NULL
,	NULL
Liverpool	NULL
,	NULL
UK	NULL
)	NULL
interfaced	NULL
to	NULL
a	NULL
single	NULL
chip	NULL
CCD	NULL
camera	NULL
(	NULL
Hitachi	NULL
Corp	NULL
Ltd	NULL
)	NULL
.	NULL

The	NULL
filters	NULL
used	NULL
were	NULL
31005D605	NULL
(	NULL
Chroma	NULL
Technology	NULL
Corp	NULL
,	NULL
Liverpool	NULL
,	NULL
UK	NULL
)	NULL
for	NULL
Texas-Red	NULL
and	NULL
31001	NULL
605	NULL
(	NULL
Chroma	NULL
Technology	NULL
Corp	NULL
)	NULL
for	NULL
fluorescein	NULL
.	NULL

Low	NULL
magnification	NULL
surveys	NULL
of	NULL
the	NULL
main	NULL
tissue	NULL
compartments	NULL
(	NULL
mucosa	NULL
,	NULL
submucosa	NULL
,	NULL
glandular	NULL
epithelium	NULL
,	NULL
blood	NULL
vessels	NULL
)	NULL
were	NULL
carried	NULL
out	NULL
and	NULL
sites	NULL
for	NULL
tissue	NULL
reactivity	NULL
scored	NULL
.	NULL

Higher	NULL
magnification	NULL
fields	NULL
of	NULL
view	NULL
(	NULL
x60	NULL
)	NULL
were	NULL
selected	NULL
by	NULL
random	NULL
tesselation	NULL
and	NULL
cell	NULL
counts	NULL
were	NULL
performed	NULL
for	NULL
ER	NULL
positive	NULL
cells	NULL
(	NULL
five	NULL
fields	NULL
in	NULL
total	NULL
)	NULL
.	NULL

Cell	NULL
counts	NULL
of	NULL
three	NULL
or	NULL
more	NULL
(	NULL
mean	NULL
Anubody	NULL
Source	NULL
Subtype	NULL
Specificity	NULL
Dilution	NULL
Supplier	NULL
Anti-ER	NULL
Rabbit	NULL
Polyclonal	NULL
All	NULL
ER	NULL
hormone	NULL
binding	NULL
sites	NULL
in	NULL
human	NULL
tissue	NULL
1:250	NULL
SINO	NULL
American	NULL
Biotechnology	NULL
Anti-PR	NULL
Rabbit	NULL
Polyclonal	NULL
All	NULL
PR	NULL
hormone	NULL
binding	NULL
sites	NULL
in	NULL
human	NULL
tissue	NULL
1:200	NULL
SINO	NULL
American	NULL
Biotechnology	NULL
AER311	NULL
(	NULL
anti-ER	NULL
)	NULL
Mouse	NULL
Monoclonal	NULL
A	NULL
defined	NULL
epitope	NULL
located	NULL
between	NULL
amino	NULL
acids	NULL
495	NULL
and	NULL
595	NULL
of	NULL
the	NULL
1:100	NULL
SeroTec	NULL
ER	NULL
hormone	NULL
binding	NULL
subunit	NULL
AAl	NULL
(	NULL
anti-mast	NULL
cell	NULL
)	NULL
Mouse	NULL
Monoclonal	NULL
Specific	NULL
for	NULL
human	NULL
mast	NULL
cell	NULL
tryptase	NULL
1:100	NULL
Dako	NULL
IF6	NULL
(	NULL
anti-CD4	NULL
)	NULL
Mouse	NULL
Monoclonal	NULL
Binds	NULL
only	NULL
to	NULL
the	NULL
helper/inducer	NULL
subpopulation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
1:100	NULL
Novocastra	NULL
C8/144B	NULL
(	NULL
anti-CD8	NULL
)	NULL
Mouse	NULL
Monoclonal	NULL
Binds	NULL
only	NULL
to	NULL
the	NULL
suppressor/cytotoxic	NULL
subpopulation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
1:100	NULL
Dako	NULL
PG-M1	NULL
(	NULL
anti-CD68	NULL
)	NULL
Mouse	NULL
Monoclonal	NULL
Specific	NULL
for	NULL
human	NULL
monocytes	NULL
and	NULL
macrophages	NULL
but	NULL
not	NULL
myeloid	NULL
1:100	NULL
Dako	NULL
www	NULL
.	NULL

thoraxjnl.com	NULL
Expression	NULL
of	NULL
oestrogen	NULL
and	NULL
progesterone	NULL
receptors	NULL
uP	NULL
C	NULL
«	NULL
%	NULL
``	NULL
=	NULL
-d	NULL
207	NULL
Figure	NULL
1	NULL
-	NULL
Paraffin	NULL
embedded	NULL
nasal	NULL
polyp	NULL
section	NULL
stained	NULL
for	NULL
oestrogen	NULL
receptor	NULL
(	NULL
ER	NULL
)	NULL
sites	NULL
with	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
.	NULL

Positive	NULL
cells	NULL
are	NULL
located	NULL
mainly	NULL
within	NULL
the	NULL
submucosal	NULL
and	NULL
deep	NULL
connective	NULL
tissue	NULL
(	NULL
a	NULL
,	NULL
indicated	NULL
by	NULL
arrow	NULL
)	NULL
.	NULL

The	NULL
area	NULL
shown	NULL
within	NULL
the	NULL
box	NULL
in	NULL
(	NULL
a	NULL
)	NULL
is	NULL
reproduced	NULL
to	NULL
show	NULL
typical	NULL
positive	NULL
cells	NULL
(	NULL
b	NULL
)	NULL
,	NULL
and	NULL
cytoplasmic	NULL
staining	NULL
(	NULL
c	NULL
)	NULL
.	NULL

Counterstained	NULL
with	NULL
haematoxylin	NULL
.	NULL

Magnification	NULL
(	NULL
a	NULL
)	NULL
x10	NULL
,	NULL
(	NULL
b	NULL
)	NULL
x40	NULL
,	NULL
(	NULL
c	NULL
)	NULL
100.	NULL
e®	NULL
cu	NULL
t*	NULL
f	NULL
if	NULL
.	NULL
``	NULL

%	NULL
.	NULL

k	NULL
``	NULL
I	NULL
--	NULL
i	NULL
-	NULL
L	NULL
2	NULL
-	NULL
i	NULL
,	NULL
-	NULL
&	NULL
``	NULL
@	NULL
|	NULL
f	NULL
s	NULL
a	NULL
i	NULL
Ve	NULL
o	NULL
*-	NULL
.-	NULL
sill	NULL
'	NULL
a	NULL
``	NULL
4	NULL
F	NULL
%	NULL
¥	NULL
t	NULL
3	NULL
#	NULL
``	NULL
.	NULL

*	NULL
%	NULL
(	NULL
3	NULL
Figure	NULL
2	NULL
-	NULL
A	NULL
``	NULL
look	NULL
up	NULL
``	NULL
tissue	NULL
section	NULL
consecutive	NULL
to	NULL
that	NULL
in	NULL
fig	NULL
1	NULL
.	NULL

Mast	NULL
cell	NULL
location	NULL
(	NULL
a	NULL
,	NULL
x10	NULL
)	NULL
is	NULL
revealed	NULL
by	NULL
toluidine	NULL
blue	NULL
staining	NULL
and	NULL
typical	NULL
cell	NULL
morphology	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
b	NULL
(	NULL
x40	NULL
)	NULL
.	NULL

For	NULL
identification	NULL
the	NULL
area	NULL
shown	NULL
in	NULL
(	NULL
b	NULL
)	NULL
appears	NULL
by	NULL
rotation	NULL
of	NULL
the	NULL
boxed	NULL
area	NULL
in	NULL
(	NULL
a	NULL
)	NULL
and	NULL
identifiable	NULL
cells	NULL
are	NULL
marked	NULL
with	NULL
arrows	NULL
.	NULL

Significant	NULL
registration	NULL
between	NULL
ER	NULL
positive	NULL
(	NULL
fig	NULL
1a	NULL
)	NULL
and	NULL
toluidine	NULL
blue	NULL
stained	NULL
mast	NULL
cells	NULL
(	NULL
fig	NULL
2a	NULL
)	NULL
is	NULL
identified	NULL
(	NULL
indicated	NULL
by	NULL
arrows	NULL
)	NULL
.	NULL

count	NULL
)	NULL
were	NULL
determined	NULL
as	NULL
positive	NULL
expression	NULL
and	NULL
counts	NULL
of	NULL
greater	NULL
than	NULL
nine	NULL
were	NULL
considered	NULL
as	NULL
high	NULL
expression	NULL
.	NULL

Unreactive	NULL
mast	NULL
cells	NULL
were	NULL
scored	NULL
as	NULL
a	NULL
ratio	NULL
to	NULL
immunopositive	NULL
mast	NULL
cells	NULL
.	NULL

ANALYSIS	NULL
OF	NULL
DATA	NULL
Statistical	NULL
analyses	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
SPSS	NULL
package	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
(	NULL
SD	NULL
)	NULL
per	NULL
high	NULL
power	NULL
field	NULL
for	NULL
each	NULL
specimen	NULL
.	NULL

Two	NULL
tailed	NULL
Pearson	NULL
bivariate	NULL
correlation	NULL
analysis	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
correlation	NULL
coeffi-	NULL
|_	NULL
lag	NULL
l-i	NULL
©	NULL
h	NULL
@	NULL
#	NULL
%	NULL
@	NULL
-	NULL
®	NULL
le	NULL
T	NULL
u-	NULL
**	NULL
``	NULL
.+	NULL
*C	NULL
£	NULL
®	NULL
O	NULL
Figure	NULL
3	NULL
-	NULL
Paraffin	NULL
embedded	NULL
section	NULL
of	NULL
a	NULL
human	NULL
nasal	NULL
polyp	NULL
.	NULL

The	NULL
characteristics	NULL
of	NULL
different	NULL
immune	NULL
cell	NULL
populations	NULL
in	NULL
nasal	NULL
polyps	NULL
were	NULL
immunohistochemically	NULL
shown	NULL
by	NULL
their	NULL
relevant	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

The	NULL
expected	NULL
lymphoid	NULL
characteristics	NULL
(	NULL
regular	NULL
shaped	NULL
nucleus	NULL
,	NULL
agranular	NULL
cytoplasm	NULL
)	NULL
were	NULL
present	NULL
in	NULL
cells	NULL
stained	NULL
with	NULL
CD8/144B	NULL
for	NULL
T	NULL
cytotoxic/suppressor	NULL
cells	NULL
.	NULL

A	NULL
great	NULL
number	NULL
of	NULL
eosinophils	NULL
and	NULL
some	NULL
neutrophils	NULL
were	NULL
also	NULL
shown	NULL
by	NULL
HE	NULL
staining	NULL
.	NULL

Counterstained	NULL
with	NULL
HE	NULL
.	NULL

Magnification	NULL
(	NULL
a	NULL
)	NULL
x40	NULL
,	NULL
(	NULL
b	NULL
)	NULL
X100	NULL
.	NULL

www	NULL
.	NULL

thoraxjnl.com	NULL
cients	NULL
(	NULL
r	NULL
)	NULL
between	NULL
the	NULL
number	NULL
of	NULL
ER	NULL
or	NULL
PR	NULL
positive	NULL
cells	NULL
and	NULL
the	NULL
number	NULL
of	NULL
mast	NULL
cells	NULL
.	NULL

Differences	NULL
in	NULL
expression	NULL
of	NULL
ER	NULL
or	NULL
PR	NULL
between	NULL
sexes	NULL
and	NULL
ages	NULL
were	NULL
assessed	NULL
by	NULL
independent	NULL
;	NULL
test	NULL
and	NULL
one	NULL
way	NULL
ANOVA	NULL
.	NULL

A	NULL
p	NULL
value	NULL
of	NULL
<	NULL
0.05	NULL
was	NULL
considered	NULL
to	NULL
indicate	NULL
significance	NULL
.	NULL

Results	NULL
IMMUNOHISTOCHEMICAL	NULL
REACTIVITY	NULL
FOR	NULL
ER	NULL
OR	NULL
PR	NULL
STAINING	NULL
AND	NULL
ITS	NULL
CO-LOCALISATION	NULL
WITH	NULL
TISSUE	NULL
MAST	NULL
CELLS	NULL
IN	NULL
NASAL	NULL
POLYPS	NULL
The	NULL
results	NULL
show	NULL
that	NULL
upper	NULL
airway	NULL
nasal	NULL
polyps	NULL
contain	NULL
cells	NULL
which	NULL
label	NULL
in	NULL
a	NULL
positive	NULL
fashion	NULL
for	NULL
both	NULL
ER	NULL
and	NULL
PR	NULL
(	NULL
fig	NULL
1a	NULL
,	NULL
b	NULL
,	NULL
c	NULL
)	NULL
.	NULL

The	NULL
immunoreactive	NULL
cells	NULL
to	NULL
ER	NULL
or	NULL
PR	NULL
are	NULL
all	NULL
mononuclear	NULL
,	NULL
typically	NULL
8-12	NULL
um	NULL
in	NULL
diameter	NULL
,	NULL
and	NULL
are	NULL
characterised	NULL
by	NULL
a	NULL
distinct	NULL
cytoplasm	NULL
densely	NULL
reactive	NULL
for	NULL
DAB	NULL
(	NULL
fig	NULL
1	NULL
,	NULL
insert	NULL
)	NULL
.	NULL

Consecutive	NULL
sections	NULL
(	NULL
fig	NULL
2	NULL
)	NULL
show	NULL
that	NULL
cell	NULL
projections	NULL
can	NULL
be	NULL
``	NULL
mapped	NULL
``	NULL
into	NULL
at	NULL
least	NULL
one	NULL
adjacent	NULL
plane	NULL
.	NULL

Thus	NULL
,	NULL
sites	NULL
positive	NULL
for	NULL
ER	NULL
appear	NULL
to	NULL
be	NULL
like	NULL
mast	NULL
cells	NULL
in	NULL
adjacent	NULL
sections	NULL
when	NULL
stained	NULL
with	NULL
toluidine	NULL
blue	NULL
.	NULL

The	NULL
high	NULL
degree	NULL
of	NULL
tissue	NULL
registration	NULL
found	NULL
to	NULL
exist	NULL
between	NULL
ER	NULL
positive	NULL
and	NULL
toluidine	NULL
blue	NULL
positive	NULL
cellular	NULL
elements	NULL
appears	NULL
consistent	NULL
with	NULL
tissue	NULL
reactivity	NULL
being	NULL
due	NULL
to	NULL
stromal	NULL
mast	NULL
cells	NULL
.	NULL
``	NULL

``	NULL
EXPRESSION	NULL
OF	NULL
ER/PR	NULL
BY	NULL
MAST	NULL
CELLS	NULL
ALONE	NULL
BUT	NULL
NOT	NULL
LYMPHOCYTES	NULL
,	NULL
MACROPHAGES	NULL
,	NULL
OR	NULL
OTHER	NULL
IMMUNE	NULL
CELLS	NULL
Additional	NULL
immunohistochemical	NULL
and	NULL
histochemical	NULL
tests	NULL
show	NULL
that	NULL
many	NULL
other	NULL
immune	NULL
cells	NULL
(	NULL
T	NULL
helper	NULL
cells	NULL
,	NULL
T	NULL
cytotoxic/suppressor	NULL
cells	NULL
,	NULL
macrophages	NULL
,	NULL
eosinophils	NULL
and	NULL
neu-trophils	NULL
)	NULL
are	NULL
present	NULL
within	NULL
nasal	NULL
polyps	NULL
(	NULL
figs	NULL
3	NULL
208	NULL
Figure	NULL
4	NULL
-	NULL
Paraffin	NULL
embedded	NULL
section	NULL
of	NULL
a	NULL
human	NULL
nasal	NULL
polyp	NULL
shawmg	NULL
PG-M1	NULL
marked	NULL
irregularly	NULL
shaped	NULL
macrophages	NULL
with	NULL
dendrite-like	NULL
projections	NULL
.	NULL

Counterstained	NULL
with	NULL
HE	NULL
.	NULL

Magnification	NULL
(	NULL
a	NULL
)	NULL
x10	NULL
,	NULL
(	NULL
b	NULL
)	NULL
100	NULL
.	NULL

~	NULL
=	NULL
``	NULL
Aa	NULL
I	NULL
&	NULL
.	NULL

®	NULL
@	NULL
*	NULL
®	NULL
.	NULL

,	NULL
ll	NULL
:	NULL
-	NULL
%	NULL
f	NULL
a	NULL
ya	NULL
**	NULL
at	NULL
``	NULL
%	NULL
a	NULL
a	NULL
i	NULL
+4	NULL
w	NULL
#	NULL
#	NULL
»	NULL
®	NULL
it	NULL
:	NULL
I'|_I	NULL
f	NULL
=	NULL
<	NULL
e\	NULL
«	NULL
«	NULL
.	NULL

``	NULL
*	NULL
}	NULL
The	NULL
%	NULL
to	NULL
#	NULL
__	NULL
&	NULL
a	NULL
ha	NULL
:	NULL
&	NULL
*	NULL
*	NULL
*a	NULL
an	NULL
a	NULL
tie	NULL
.h-1	NULL
®	NULL
4	NULL
``	NULL
*-	NULL
.	NULL

E	NULL
}	NULL
:	NULL
+	NULL
f	NULL
4	NULL
!	NULL

a	NULL
£	NULL
-	NULL
.	NULL

L	NULL
k	NULL
#	NULL
#	NULL
wo	NULL
[	NULL
+++	NULL
*	NULL
&	NULL
A	NULL
“	NULL
ank	NULL
%	NULL
a	NULL
‘	NULL
r	NULL
‘	NULL
uri	NULL
'	NULL
u-	NULL
P	NULL
$	NULL
,	NULL
``	NULL
%	NULL
*	NULL
%	NULL
'-	NULL
--	NULL
*	NULL
a	NULL
_	NULL
2d	NULL
A	NULL
a	NULL
a	NULL
o	NULL
fl	NULL
”	NULL
»	NULL
W*ap*	NULL
w	NULL
I	NULL
&	NULL
e	NULL
*	NULL
g	NULL
E	NULL
m	NULL
-	NULL
.	NULL

im	NULL
©	NULL
(	NULL
®	NULL
io	NULL
s	NULL
o	NULL
&	NULL
%	NULL
m	NULL
%	NULL
s	NULL
l	NULL
``	NULL
l	NULL
a	NULL
,	NULL
.	NULL

#	NULL
A	NULL
#	NULL
uk	NULL
1	NULL
.	NULL

§	NULL
i	NULL
A	NULL
w	NULL
a	NULL
f	NULL
:	NULL
hus	NULL
y	NULL
an	NULL
*	NULL
Tru	NULL
s	NULL
wi	NULL
,	NULL
in	NULL
.	NULL

yA	NULL
an	NULL
ls	NULL
ij	NULL
#	NULL
%	NULL
ig	NULL
aay	NULL
£	NULL
o	NULL
*	NULL
fo	NULL
Figure	NULL
5	NULL
-	NULL
Paraffin	NULL
embedded	NULL
section	NULL
of	NULL
a	NULL
human	NULL
nasal	NULL
polyp	NULL
.	NULL

Only	NULL
the	NULL
cells	NULL
immunohistochemically	NULL
labelled	NULL
by	NULL
monoclonal	NULL
antibody	NULL
AA1	NULL
for	NULL
mast	NULL
cell	NULL
tryptase	NULL
were	NULL
morphologically	NULL
identical	NULL
to	NULL
the	NULL
cells	NULL
marked	NULL
with	NULL
antibodies	NULL
for	NULL
ER	NULL
(	NULL
fig	NULL
1a	NULL
,	NULL
b	NULL
and	NULL
fig	NULL
6a	NULL
,	NULL
b	NULL
)	NULL
.	NULL

Counterstained	NULL
with	NULL
HE	NULL
.	NULL

Magnification	NULL
(	NULL
a	NULL
)	NULL
x10	NULL
,	NULL
(	NULL
b	NULL
)	NULL
100	NULL
.	NULL

#	NULL
€	NULL
3	NULL
a*	NULL
=	NULL
#	NULL
%	NULL
is	NULL
``	NULL
+M	NULL
u	NULL
¥	NULL
I	NULL
%	NULL
,	NULL
a	NULL
#	NULL
g.	NULL
k	NULL
,	NULL
USF	NULL
.	NULL

te	NULL
«	NULL
t	NULL
s	NULL
&	NULL
T	NULL
#	NULL
+	NULL
a	NULL
x	NULL
ata	NULL
®	NULL
.	NULL

=	NULL
%	NULL
'	NULL
_-	NULL
'	NULL
“	NULL
|	NULL
.	NULL

¢	NULL
®	NULL
I	NULL
‘	NULL
-	NULL
A	NULL
wo	NULL
``	NULL
``	NULL
m	NULL
P	NULL
¢	NULL
=	NULL
a	NULL
h.	NULL
elig	NULL
#	NULL
o	NULL
=	NULL
®	NULL
L	NULL
ve	NULL
a	NULL
w	NULL
9	NULL
%	NULL
w	NULL
C	NULL
t	NULL
T	NULL
#	NULL
.	NULL

F.	NULL
a	NULL
‘	NULL
1_	NULL
-	NULL
‘	NULL
#	NULL
t	NULL
.	NULL

aco	NULL
a	NULL
*	NULL
.	NULL

dl	NULL
+	NULL
``	NULL
w	NULL
``	NULL
4	NULL
1	NULL
a	NULL
i	NULL
'	NULL
Figure	NULL
6	NULL
-	NULL
Nasal	NULL
polyp	NULL
tissue	NULL
exhibiting	NULL
a	NULL
positive	NULL
reaction	NULL
for	NULL
high	NULL
affinity	NULL
monoclonal	NULL
antibody	NULL
against	NULL
ER	NULL
(	NULL
AER311	NULL
)	NULL
.	NULL

Distribution	NULL
of	NULL
positive	NULL
cells	NULL
(	NULL
a	NULL
)	NULL
appears	NULL
similar	NULL
to	NULL
fig	NULL
1	NULL
and	NULL
higher	NULL
magnification	NULL
detail	NULL
(	NULL
b	NULL
)	NULL
of	NULL
the	NULL
area	NULL
indicated	NULL
by	NULL
a	NULL
black	NULL
arrow	NULL
defines	NULL
pasm	NULL
've	NULL
cells	NULL
to	NULL
be	NULL
distinct	NULL
cytoplasmic	NULL
lear	NULL
cells	NULL
.	NULL

Toluidine	NULL
blue	NULL
c	NULL
g	NULL
of	NULL
such	NULL
tissue	NULL
section	NULL
reveals	NULL
that	NULL
some	NULL
mast	NULL
cells	NULL
(	NULL
indicated	NULL
by	NULL
a	NULL
red	NULL
arrow	NULL
)	NULL
develop	NULL
a	NULL
typzcal	NULL
basophzhc	NULL
cytoplasmu	NULL
:	NULL
staining	NULL
pattern	NULL
(	NULL
c	NULL
)	NULL
repr	NULL
ive	NULL
of	NULL
cells	NULL
p	NULL
ly	NULL
for	NULL
ER	NULL
immunostaining	NULL
.	NULL

Magnification	NULL
(	NULL
a	NULL
)	NULL
x10	NULL
,	NULL
(	NULL
b	NULL
)	NULL
x100	NULL
,	NULL
(	NULL
c	NULL
)	NULL
x60	NULL
.	NULL

www	NULL
.	NULL

thoraxjnl.com	NULL
Zhao	NULL
,	NULL
McKerr	NULL
,	NULL
Zhen	NULL
,	NULL
et	NULL
al	NULL
and	NULL
4	NULL
)	NULL
.	NULL

°	NULL
These	NULL
additional	NULL
cells	NULL
stain	NULL
appropriately	NULL
within	NULL
histological	NULL
sections	NULL
for	NULL
their	NULL
specific	NULL
antigen	NULL
,	NULL
appear	NULL
morphologically	NULL
true	NULL
to	NULL
cell	NULL
type	NULL
,	NULL
yet	NULL
remain	NULL
unreactive	NULL
for	NULL
ER	NULL
under	NULL
all	NULL
circumstances	NULL
.	NULL

Polynucleic	NULL
cells	NULL
such	NULL
as	NULL
eosinophils	NULL
and	NULL
neutrophils	NULL
(	NULL
fig	NULL
3	NULL
)	NULL
can	NULL
be	NULL
excluded	NULL
as	NULL
a	NULL
source	NULL
of	NULL
immuno	NULL
signal	NULL
for	NULL
ER	NULL
as	NULL
ER	NULL
or	NULL
PR	NULL
positive	NULL
cells	NULL
are	NULL
all	NULL
mononuclear	NULL
.	NULL

Only	NULL
mast	NULL
cell	NULL
tryptase	NULL
activity	NULL
(	NULL
fig	NULL
5	NULL
)	NULL
appears	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
ER	NULL
or	NULL
PR	NULL
positive	NULL
staining	NULL
(	NULL
figs	NULL
1	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Co-localisation	NULL
for	NULL
mast	NULL
cell	NULL
tryptase	NULL
and	NULL
ER	NULL
or	NULL
PR	NULL
is	NULL
further	NULL
consolidated	NULL
by	NULL
use	NULL
of	NULL
dual	NULL
immunofluorescence	NULL
imaging	NULL
(	NULL
figs	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Tissue	NULL
samples	NULL
stained	NULL
sequentially	NULL
for	NULL
mast	NULL
cell	NULL
tryptase	NULL
followed	NULL
by	NULL
ER	NULL
(	NULL
fig	NULL
7	NULL
)	NULL
or	NULL
for	NULL
PR	NULL
followed	NULL
by	NULL
mast	NULL
cell	NULL
tryptase	NULL
(	NULL
fig	NULL
8	NULL
)	NULL
(	NULL
each	NULL
reported	NULL
by	NULL
a	NULL
different	NULL
fluorochrome	NULL
)	NULL
and	NULL
imaged	NULL
using	NULL
interference	NULL
filters	NULL
show	NULL
the	NULL
two	NULL
signals	NULL
to	NULL
coexist	NULL
within	NULL
the	NULL
same	NULL
cell	NULL
.	NULL

Exclusion	NULL
of	NULL
other	NULL
possible	NULL
signal	NULL
sources	NULL
appears	NULL
complete	NULL
when	NULL
DAB	NULL
staining	NULL
for	NULL
immune	NULL
cell	NULL
morphology	NULL
fails	NULL
to	NULL
exhibit	NULL
ER	NULL
immunofluorescence	NULL
while	NULL
other	NULL
cells	NULL
from	NULL
within	NULL
the	NULL
same	NULL
section	NULL
are	NULL
immunopositive	NULL
(	NULL
fig	NULL
9	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
similar	NULL
results	NULL
have	NULL
been	NULL
obtained	NULL
here	NULL
from	NULL
three	NULL
peripheral	NULL
blood	NULL
samples	NULL
(	NULL
randomly	NULL
selected	NULL
from	NULL
patients	NULL
presenting	NULL
with	NULL
nasal	NULL
polyps	NULL
or	NULL
rhinitis	NULL
)	NULL
and	NULL
two	NULL
bone	NULL
marrow	NULL
trephines	NULL
from	NULL
a	NULL
48	NULL
year	NULL
old	NULL
male	NULL
patient	NULL
with	NULL
myeloproliferative	NULL
disorder	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

MORE	NULL
THAN	NULL
95	NULL
%	NULL
OF	NULL
MAST	NULL
CELLS	NULL
EXPRESS	NULL
ER/PR	NULL
IN	NULL
NASAL	NULL
POLYPS	NULL
The	NULL
numerical	NULL
relationship	NULL
between	NULL
sex	NULL
hormone	NULL
receptor	NULL
sites	NULL
and	NULL
mast	NULL
cell	NULL
number	NULL
was	NULL
investigated	NULL
using	NULL
consecutive	NULL
sections	NULL
from	NULL
47	NULL
subjects	NULL
.	NULL

The	NULL
first	NULL
section	NULL
(	NULL
plane	NULL
0	NULL
)	NULL
was	NULL
stained	NULL
for	NULL
ER	NULL
or	NULL
PR	NULL
and	NULL
the	NULL
adjacent	NULL
``	NULL
look	NULL
up	NULL
``	NULL
plane	NULL
stained	NULL
with	NULL
toluidine	NULL
blue	NULL
.	NULL

Area	NULL
matched	NULL
fields	NULL
of	NULL
view	NULL
were	NULL
selected	NULL
within	NULL
the	NULL
submu-cosa	NULL
at	NULL
low	NULL
magnification	NULL
and	NULL
cell	NULL
counts	NULL
carried	NULL
out	NULL
using	NULL
a	NULL
60:1	NULL
lens	NULL
.	NULL

When	NULL
analysed	NULL
using	NULL
a	NULL
two	NULL
tailed	NULL
Pearson	NULL
bivariate	NULL
correlation	NULL
test	NULL
,	NULL
the	NULL
correlation	NULL
between	NULL
ER	NULL
or	NULL
PR	NULL
positive	NULL
cells	NULL
and	NULL
mast	NULL
cells	NULL
was	NULL
0.973	NULL
(	NULL
p	NULL
<	NULL
0.001	NULL
)	NULL
and	NULL
0.955	NULL
(	NULL
p	NULL
<	NULL
0.001	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Despite	NULL
the	NULL
high	NULL
correlation	NULL
it	NULL
would	NULL
appear	NULL
that	NULL
not	NULL
all	NULL
mast	NULL
cells	NULL
sampled	NULL
in	NULL
this	NULL
study	NULL
are	NULL
positive	NULL
for	NULL
ER	NULL
or	NULL
PR	NULL
.	NULL

In	NULL
pursuit	NULL
of	NULL
mast	NULL
cells	NULL
negative	NULL
for	NULL
both	NULL
hormone	NULL
receptor	NULL
sites	NULL
,	NULL
21	NULL
randomly	NULL
selected	NULL
ER	NULL
positive	NULL
sections	NULL
were	NULL
stained	NULL
for	NULL
varying	NULL
time	NULL
periods	NULL
with	NULL
toluidine	NULL
blue	NULL
.	NULL

Although	NULL
absorption	NULL
characteristics	NULL
for	NULL
receptor	NULL
site	NULL
positive	NULL
cells	NULL
shifted	NULL
towards	NULL
the	NULL
longer	NULL
region	NULL
of	NULL
the	NULL
spectrum	NULL
,	NULL
typical	NULL
toluidine	NULL
blue	NULL
positive	NULL
cells	NULL
could	NULL
only	NULL
be	NULL
found	NULL
in	NULL
six	NULL
of	NULL
the	NULL
21	NULL
cases	NULL
investigated	NULL
.	NULL

Here	NULL
immuno-negative	NULL
,	NULL
toluidine	NULL
blue	NULL
positive	NULL
mast	NULL
cells	NULL
(	NULL
fig	NULL
6c	NULL
)	NULL
accounted	NULL
for	NULL
only	NULL
2.77	NULL
(	NULL
1.6	NULL
)	NULL
%	NULL
of	NULL
cells	NULL
(	NULL
n=6	NULL
)	NULL
.	NULL

NUMEROUS	NULL
ER/PR	NULL
POSITIVE	NULL
MAST	NULL
CELLS	NULL
EXIST	NULL
IN	NULL
NASAL	NULL
POLYPS	NULL
INDEPENDENT	NULL
OF	NULL
SEX	NULL
AND	NULL
AGE	NULL
Approximately	NULL
62	NULL
%	NULL
of	NULL
all	NULL
samples	NULL
examined	NULL
(	NULL
29	NULL
of	NULL
47	NULL
patients	NULL
)	NULL
were	NULL
positive	NULL
for	NULL
ER	NULL
and	NULL
above	NULL
the	NULL
threshold	NULL
for	NULL
cell	NULL
counts	NULL
.	NULL

Positive	NULL
expression	NULL
for	NULL
PR	NULL
was	NULL
recorded	NULL
in	NULL
approximately	NULL
60	NULL
%	NULL
of	NULL
cases	NULL
(	NULL
28	NULL
of	NULL
47	NULL
patients	NULL
)	NULL
.	NULL

Cases	NULL
with	NULL
high	NULL
expression	NULL
for	NULL
sex	NULL
hormone	NULL
receptor	NULL
Expression	NULL
of	NULL
oestrogen	NULL
and	NULL
progesterone	NULL
receptors	NULL
Figure	NULL
7	NULL
-	NULL
Single	NULL
paraffin	NULL
embedded	NULL
section	NULL
of	NULL
a	NULL
human	NULL
nasal	NULL
polyp	NULL
dual	NULL
labelled	NULL
for	NULL
ER	NULL
and	NULL
mast	NULL
cell	NULL
tryptase	NULL
.	NULL

Immunofiuorescence	NULL
staining	NULL
shows	NULL
that	NULL
the	NULL
location	NULL
of	NULL
the	NULL
positive	NULL
cells	NULL
(	NULL
a	NULL
,	NULL
green	NULL
)	NULL
labelled	NULL
with	NULL
AER311	NULL
(	NULL
monoclonal	NULL
antibody	NULL
for	NULL
ER	NULL
)	NULL
coincided	NULL
exactly	NULL
with	NULL
cells	NULL
marked	NULL
with	NULL
the	NULL
AA1	NULL
for	NULL
mast	NULL
cell	NULL
tryptase	NULL
(	NULL
b	NULL
,	NULL
Texas	NULL
Red	NULL
)	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Immunofluorescence/	NULL
filter	NULL
31001605	NULL
;	NULL
(	NULL
b	NULL
)	NULL
immuno-Texas	NULL
Red/filter	NULL
31005D605	NULL
.	NULL

Magnification	NULL
x60	NULL
.	NULL

Figure	NULL
8	NULL
-	NULL
Single	NULL
paraffin	NULL
embedded	NULL
section	NULL
of	NULL
a	NULL
human	NULL
nasal	NULL
polyp	NULL
dual	NULL
labelled	NULL
for	NULL
PR	NULL
and	NULL
mast	NULL
cell	NULL
tryptase	NULL
.	NULL

Immuno-Texas	NULL
Red	NULL
staining	NULL
shows	NULL
the	NULL
location	NULL
of	NULL
the	NULL
positive	NULL
cells	NULL
(	NULL
a	NULL
,	NULL
red	NULL
)	NULL
labelled	NULL
with	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
for	NULL
PR	NULL
coincided	NULL
exactly	NULL
with	NULL
cells	NULL
marked	NULL
with	NULL
the	NULL
AA1	NULL
for	NULL
mast	NULL
cell	NULL
tryptase	NULL
(	NULL
b	NULL
,	NULL
green	NULL
)	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Immuno-Texas	NULL
Red/filter	NULL
31005D605	NULL
;	NULL
(	NULL
b	NULL
)	NULL
immunofluorescence/filter	NULL
31001605	NULL
.	NULL

Magnification	NULL
x60	NULL
.	NULL

sites	NULL
accounted	NULL
for	NULL
24	NULL
patients	NULL
for	NULL
ER	NULL
and	NULL
20	NULL
patients	NULL
for	NULL
PR	NULL
.	NULL

To	NULL
see	NULL
if	NULL
the	NULL
expression	NULL
of	NULL
ER	NULL
or	NULL
PR	NULL
is	NULL
subject	NULL
to	NULL
a	NULL
sex	NULL
related	NULL
effect	NULL
,	NULL
the	NULL
scores	NULL
for	NULL
men	NULL
and	NULL
for	NULL
women	NULL
were	NULL
compared	NULL
in	NULL
18	NULL
age	NULL
matched	NULL
cases	NULL
(	NULL
women	NULL
,	NULL
mean	NULL
(	NULL
SD	NULL
)	NULL
age	NULL
31.2	NULL
(	NULL
6.3	NULL
)	NULL
years	NULL
,	NULL
range	NULL
22-42	NULL
years	NULL
,	NULL
n=9	NULL
;	NULL
men	NULL
,	NULL
mean	NULL
(	NULL
SD	NULL
)	NULL
age	NULL
32.4	NULL
(	NULL
6.0	NULL
)	NULL
years	NULL
,	NULL
range	NULL
21-42	NULL
years	NULL
,	NULL
n=9	NULL
)	NULL
.	NULL

In	NULL
men	NULL
the	NULL
mean	NULL
(	NULL
SE	NULL
)	NULL
score	NULL
was	NULL
8.4	NULL
(	NULL
1.24	NULL
)	NULL
for	NULL
ER	NULL
positive	NULL
cells	NULL
and	NULL
7.7	NULL
(	NULL
1.43	NULL
)	NULL
for	NULL
PR	NULL
positive	NULL
cells	NULL
,	NULL
while	NULL
in	NULL
women	NULL
the	NULL
mean	NULL
(	NULL
SE	NULL
)	NULL
scores	NULL
were	NULL
7.4	NULL
(	NULL
1.7	NULL
)	NULL
and	NULL
6.3	NULL
(	NULL
1.6	NULL
)	NULL
for	NULL
ER	NULL
positive	NULL
and	NULL
PR	NULL
positive	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

Neither	NULL
ER	NULL
(	NULL
p=0.620	NULL
)	NULL
nor	NULL
PR	NULL
(	NULL
p=0.517	NULL
)	NULL
expression	NULL
was	NULL
dependent	NULL
on	NULL
patient	NULL
sex	NULL
.	NULL

To	NULL
see	NULL
if	NULL
the	NULL
expression	NULL
of	NULL
ER	NULL
or	NULL
PR	NULL
can	NULL
be	NULL
influenced	NULL
by	NULL
age	NULL
,	NULL
comparisons	NULL
were	NULL
made	NULL
between	NULL
different	NULL
age	NULL
groups	NULL
(	NULL
mixed	NULL
sexes	NULL
)	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
table	NULL
2	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
www	NULL
.	NULL

thoraxjnl.com	NULL
209	NULL
expression	NULL
of	NULL
ER	NULL
or	NULL
PR	NULL
did	NULL
not	NULL
vary	NULL
with	NULL
patient	NULL
age	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
total	NULL
number	NULL
of	NULL
receptor	NULL
site	NULL
positive	NULL
mast	NULL
cells	NULL
does	NULL
not	NULL
vary	NULL
significantly	NULL
with	NULL
sex	NULL
or	NULL
age	NULL
.	NULL

Discussion	NULL
Demonstration	NULL
of	NULL
ER	NULL
in	NULL
tissues	NULL
has	NULL
been	NULL
achieved	NULL
by	NULL
three	NULL
approaches	NULL
:	NULL
DCC	NULL
,	NULL
enzyme	NULL
immunoassay	NULL
(	NULL
EIA	NULL
)	NULL
,	NULL
and	NULL
immunohistochemis-try	NULL
.	NULL

The	NULL
latter	NULL
technique	NULL
is	NULL
considered	NULL
to	NULL
be	NULL
superior	NULL
to	NULL
others	NULL
because	NULL
it	NULL
allows	NULL
in	NULL
situ	NULL
demonstration	NULL
of	NULL
ER	NULL
,	NULL
so	NULL
that	NULL
the	NULL
possibility	NULL
of	NULL
sample	NULL
contamination	NULL
by	NULL
non-relevant	NULL
cells	NULL
or	NULL
tissue	NULL
,	NULL
which	NULL
is	NULL
possible	NULL
with	NULL
DCC	NULL
,	NULL
is	NULL
ex-cluded	NULL
.	NULL
``	NULL

Using	NULL
immunohistochemistry	NULL
,	NULL
the	NULL
present	NULL
study	NULL
has	NULL
shown	NULL
that	NULL
nasal	NULL
polyp	NULL
tissues	NULL
contain	NULL
numerous	NULL
ER	NULL
and/or	NULL
PR	NULL
positive	NULL
cells	NULL
.	NULL

These	NULL
ER	NULL
and/or	NULL
PR	NULL
positive	NULL
cells	NULL
were	NULL
identified	NULL
as	NULL
being	NULL
restricted	NULL
to	NULL
mast	NULL
cells	NULL
only	NULL
by	NULL
parallel	NULL
toluidine	NULL
blue	NULL
staining	NULL
for	NULL
mast	NULL
cells	NULL
on	NULL
serial	NULL
sections	NULL
and	NULL
dual	NULL
immunostaining	NULL
using	NULL
high	NULL
affinity	NULL
antibodies	NULL
for	NULL
ER	NULL
or	NULL
PR	NULL
and	NULL
for	NULL
CD4+	NULL
,	NULL
CD8+	NULL
,	NULL
CD68+	NULL
,	NULL
or	NULL
mast	NULL
cell	NULL
tryptase	NULL
.	NULL

This	NULL
finding	NULL
not	NULL
only	NULL
provides	NULL
for	NULL
the	NULL
first	NULL
time	NULL
site	NULL
specific	NULL
evidence	NULL
for	NULL
the	NULL
reported	NULL
sex	NULL
hormone	NULL
effect	NULL
in	NULL
airways	NULL
,	NULL
``	NULL
but	NULL
may	NULL
aid	NULL
understanding	NULL
of	NULL
the	NULL
possible	NULL
mechanisms	NULL
by	NULL
which	NULL
these	NULL
effects	NULL
are	NULL
mediated	NULL
.	NULL

Mast	NULL
cells	NULL
are	NULL
key	NULL
effector	NULL
cells	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
allergic	NULL
disorders	NULL
and	NULL
chronic	NULL
inflammatory	NULL
diseases	NULL
including	NULL
nasal	NULL
polyposis	NULL
and	NULL
asthma	NULL
.	NULL

It	NULL
is	NULL
well	NULL
known	NULL
that	NULL
degranulation	NULL
of	NULL
mast	NULL
cells	NULL
leads	NULL
to	NULL
both	NULL
microvascular	NULL
and	NULL
cellular	NULL
responses	NULL
,	NULL
causing	NULL
contractions	NULL
and	NULL
rapid	NULL
oedema	NULL
of	NULL
smooth	NULL
muscles	NULL
and	NULL
mobilising	NULL
other	NULL
inflammatory	NULL
cells	NULL
to	NULL
enter	NULL
the	NULL
inflammatory	NULL
site	NULL
.	NULL
``	NULL

''	NULL
The	NULL
more	NULL
recent	NULL
discovery	NULL
that	NULL
mast	NULL
cells	NULL
are	NULL
sources	NULL
of	NULL
cytokines	NULL
``	NULL
which	NULL
play	NULL
key	NULL
roles	NULL
in	NULL
signal	NULL
transduction	NULL
and	NULL
communication	NULL
between	NULL
immune	NULL
cells	NULL
suggests	NULL
that	NULL
mast	NULL
cell	NULL
activation	NULL
could	NULL
influence	NULL
the	NULL
development	NULL
of	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
responses	NULL
.	NULL
``	NULL

Mast	NULL
cells	NULL
may	NULL
also	NULL
be	NULL
necessary	NULL
for	NULL
activation	NULL
and	NULL
regulation	NULL
of	NULL
eosinophil	NULL
``	NULL
and	NULL
macrophage	NULL
func-tions	NULL
.	NULL
``	NULL

Hence	NULL
,	NULL
our	NULL
finding	NULL
of	NULL
expression	NULL
of	NULL
ER/PR	NULL
by	NULL
mast	NULL
cells	NULL
alone-but	NULL
not	NULL
lymphocytes	NULL
,	NULL
macrophages	NULL
or	NULL
other	NULL
immune	NULL
cells-expanding	NULL
the	NULL
functional	NULL
implications	NULL
of	NULL
mast	NULL
cells	NULL
,	NULL
suggests	NULL
that	NULL
mast	NULL
cells	NULL
may	NULL
be	NULL
the	NULL
primary	NULL
target	NULL
responsible	NULL
for	NULL
sex	NULL
hormone	NULL
effects	NULL
in	NULL
airways	NULL
.	NULL

Although	NULL
earlier	NULL
studies	NULL
reported	NULL
specific	NULL
oestrogen	NULL
binding	NULL
sites	NULL
using	NULL
the	NULL
whole	NULL
cell	NULL
culture	NULL
or	NULL
DCC	NULL
method	NULL
on	NULL
the	NULL
human	NULL
peripheral	NULL
T	NULL
suppressor/cytotoxic	NULL
subset	NULL
``	NULL
and	NULL
on	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
,	NULL
``	NULL
more	NULL
recent	NULL
studies	NULL
with	NULL
immunohistochemistry	NULL
have	NULL
shown	NULL
different	NULL
results	NULL
.	NULL

Pang	NULL
et	NULL
al	NULL
demonstrated	NULL
bladder	NULL
mast	NULL
cell	NULL
expression	NULL
of	NULL
high	NULL
affinity	NULL
oestrogen	NULL
receptors	NULL
in	NULL
patients	NULL
with	NULL
interstitial	NULL
cystitis	NULL
.	NULL
``	NULL

King	NULL
et	NULL
aP	NULL
``	NULL
also	NULL
reported	NULL
that	NULL
neither	NULL
lymphocytes	NULL
,	NULL
macrophages	NULL
,	NULL
nor	NULL
a	NULL
distinctive	NULL
population	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
express	NULL
oestrogen	NULL
receptors	NULL
in	NULL
uterine	NULL
mucosa	NULL
.	NULL

Our	NULL
data	NULL
with	NULL
nasal	NULL
polyposis	NULL
tissues	NULL
are	NULL
in	NULL
line	NULL
with	NULL
these	NULL
findings	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
obtained	NULL
the	NULL
same	NULL
results	NULL
with	NULL
peripheral	NULL
blood	NULL
smears	NULL
and	NULL
bone	NULL
marrow	NULL
trephine	NULL
tissues	NULL
in	NULL
the	NULL
present	NULL
study	NULL
.	NULL

210	NULL
Figure	NULL
9	NULL
-	NULL
Two	NULL
sections	NULL
of	NULL
a	NULL
paraffin	NULL
embedded	NULL
human	NULL
nasal	NULL
polyp	NULL
dual	NULL
labelled	NULL
for	NULL
ER	NULL
and	NULL
for	NULL
other	NULL
immune	NULL
cell	NULL
types	NULL
.	NULL

Dual	NULL
immunostaining	NULL
shows	NULL
that	NULL
the	NULL
location	NULL
of	NULL
CD8+	NULL
cells	NULL
(	NULL
T	NULL
cytotoxic/suppressor	NULL
)	NULL
(	NULL
a	NULL
,	NULL
indicated	NULL
with	NULL
an	NULL
arrow	NULL
)	NULL
or	NULL
CD68+	NULL
cells	NULL
(	NULL
macrophages	NULL
)	NULL
(	NULL
CA	NULL
1ndzcated	NULL
with	NULL
an	NULL
arrow	NULL
)	NULL
dzﬂfers	NULL
from	NULL
that	NULL
of	NULL
ER	NULL
posm	NULL
've	NULL
cells	NULL
(	NULL
b	NULL
,	NULL
d	NULL
)	NULL
.	NULL

Sections	NULL
were	NULL
hemically	NULL
stained	NULL
with	NULL
lonal	NULL
antibody	NULL
CD8/144B	NULL
for	NULL
T	NULL
cytotoxic	NULL
!	NULL

suppressor	NULL
cells	NULL
(	NULL
a	NULL
,	NULL
magnification	NULL
X60	NULL
)	NULL
or	NULL
PG-M1	NULL
for	NULL
macrophages	NULL
(	NULL
c	NULL
,	NULL
magnification	NULL
x60	NULL
)	NULL
followed	NULL
by	NULL
immunofluorescence	NULL
c	NULL
ining	NULL
with	NULL
lonal	NULL
body	NULL
AER311	NULL
for	NULL
ER	NULL
(	NULL
b	NULL
and	NULL
d	NULL
,	NULL
magnification	NULL
x60	NULL
)	NULL
.	NULL

(	NULL
a	NULL
)	NULL
and	NULL
(	NULL
b	NULL
)	NULL
were	NULL
from	NULL
one	NULL
section	NULL
;	NULL
(	NULL
c	NULL
)	NULL
and	NULL
(	NULL
d	NULL
)	NULL
were	NULL
from	NULL
another	NULL
section	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
positive	NULL
expression	NULL
of	NULL
ER	NULL
and/or	NULL
PR	NULL
in	NULL
nasal	NULL
polyp	NULL
tissues	NULL
was	NULL
61.7	NULL
%	NULL
and/or	NULL
59.6	NULL
%	NULL
.	NULL

Among	NULL
these	NULL
positive	NULL
nasal	NULL
polyp	NULL
tissues	NULL
,	NULL
most	NULL
showed	NULL
high	NULL
expression	NULL
of	NULL
ER	NULL
or	NULL
PR	NULL
,	NULL
as	NULL
evaluated	NULL
by	NULL
scoring	NULL
the	NULL
number	NULL
of	NULL
the	NULL
ER	NULL
and/or	NULL
PR	NULL
positive	NULL
cells	NULL
.	NULL

Further	NULL
correlation	NULL
studies	NULL
between	NULL
the	NULL
number	NULL
of	NULL
ER	NULL
or	NULL
PR	NULL
positive	NULL
cells	NULL
and	NULL
that	NULL
of	NULL
mast	NULL
cells	NULL
(	NULL
coefficient	NULL
=	NULL
0.973	NULL
,	NULL
p	NULL
<	NULL
0.001	NULL
for	NULL
ER	NULL
;	NULL
0.955	NULL
,	NULL
p	NULL
<	NULL
0.001	NULL
for	NULL
PR	NULL
)	NULL
showed	NULL
that	NULL
more	NULL
than	NULL
95	NULL
%	NULL
of	NULL
mast	NULL
cells	NULL
sampled	NULL
in	NULL
this	NULL
study	NULL
express	NULL
ER	NULL
and/or	NULL
PR	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
such	NULL
a	NULL
considerable	NULL
number	NULL
of	NULL
mast	NULL
cells	NULL
express	NULL
ER/PR	NULL
in	NULL
nasal	NULL
polyp	NULL
tissues	NULL
suggests	NULL
that	NULL
this	NULL
may	NULL
be	NULL
a	NULL
major	NULL
route	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
sex	NULL
hormones	NULL
in	NULL
the	NULL
development	NULL
of	NULL
nasal	NULL
polyposis	NULL
and	NULL
asthma	NULL
when	NULL
exposed	NULL
to	NULL
a	NULL
high	NULL
and	NULL
fluctuating	NULL
sex	NULL
hormone	NULL
environment	NULL
.	NULL

Functional	NULL
heterogeneity	NULL
of	NULL
human	NULL
airway	NULL
mast	NULL
cells	NULL
has	NULL
been	NULL
reported	NULL
from	NULL
different	NULL
microenvironments	NULL
within	NULL
human	NULL
nasal	NULL
polyp	NULL
tissue	NULL
.	NULL
``	NULL

The	NULL
distribution	NULL
and	NULL
numbers	NULL
of	NULL
mast	NULL
cells	NULL
within	NULL
human	NULL
nasal	NULL
polyps	NULL
can	NULL
be	NULL
altered	NULL
by	NULL
different	NULL
fixation	NULL
.	NULL
``	NULL

Most	NULL
stromal	NULL
mast	NULL
cells	NULL
are	NULL
formalin	NULL
resistant	NULL
and	NULL
contain	NULL
both	NULL
tryptase	NULL
and	NULL
chymase	NULL
;	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
most	NULL
epithelial	NULL
mast	NULL
cells	NULL
are	NULL
formalin	NULL
sensitive	NULL
,	NULL
tryptase	NULL
positive	NULL
,	NULL
and	NULL
chymase	NULL
negative	NULL
.	NULL
``	NULL

Since	NULL
the	NULL
specimens	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
formalin	NULL
fixed	NULL
tissues	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
mast	NULL
cells	NULL
sampled	NULL
are	NULL
assumed	NULL
to	NULL
be	NULL
of	NULL
the	NULL
formalin	NULL
resistant	NULL
population	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
ER	NULL
and/or	NULL
PR	NULL
by	NULL
mast	NULL
cells	NULL
was	NULL
independent	NULL
of	NULL
patient	NULL
sex	NULL
and	NULL
age	NULL
and	NULL
that	NULL
fewer	NULL
than	NULL
5	NULL
%	NULL
of	NULL
the	NULL
mast	NULL
cells	NULL
sampled	NULL
in	NULL
this	NULL
study	NULL
were	NULL
negative	NULL
for	NULL
ER	NULL
and/or	NULL
PR	NULL
.	NULL

Table	NULL
2	NULL
-	NULL
Age	NULL
(	NULL
mixed	NULL
sex	NULL
)	NULL
related	NULL
cell	NULL
counts	NULL
for	NULL
ER/PR	NULL
site	NULL
staining	NULL
of	NULL
nasal	NULL
polyps	NULL
Age	NULL
group	NULL
Mean	NULL
(	NULL
SD	NULL
)	NULL
age	NULL
No	NULL
of	NULL
cases	NULL
Mean	NULL
(	NULL
SE	NULL
)	NULL
ER	NULL
Mean	NULL
(	NULL
SE	NULL
)	NULL
PR	NULL
260	NULL
65.8	NULL
(	NULL
4.5	NULL
)	NULL
7	NULL
4.97	NULL
(	NULL
1.61	NULL
)	NULL
4.12	NULL
(	NULL
1.53	NULL
)	NULL
41-59	NULL
51.4	NULL
(	NULL
5.6	NULL
)	NULL
18	NULL
6.21	NULL
(	NULL
1.07	NULL
)	NULL
5.49	NULL
(	NULL
1.09	NULL
)	NULL
16-40	NULL
30.6	NULL
(	NULL
5.0	NULL
)	NULL
16	NULL
7.73	NULL
(	NULL
1.11	NULL
)	NULL
6.97	NULL
(	NULL
1.07	NULL
)	NULL
<	NULL
15	NULL
13.7	NULL
(	NULL
1.6	NULL
)	NULL
6	NULL
8.83	NULL
(	NULL
3.13	NULL
)	NULL
7.173	NULL
(	NULL
2.98	NULL
)	NULL
ER	NULL
=	NULL
ocstrogen	NULL
receptor	NULL
;	NULL
PR	NULL
=	NULL
progesterone	NULL
receptor	NULL
.	NULL

www	NULL
.	NULL

thoraxjnl.com	NULL
Zhao	NULL
,	NULL
McKerr	NULL
,	NULL
Zhen	NULL
,	NULL
et	NULL
al	NULL
Although	NULL
this	NULL
study	NULL
provides	NULL
compelling	NULL
evidence	NULL
that	NULL
numerous	NULL
ER	NULL
and/or	NULL
PR	NULL
positive	NULL
mast	NULL
cells	NULL
exist	NULL
in	NULL
nasal	NULL
polyp	NULL
tissues	NULL
independent	NULL
of	NULL
patient	NULL
sex	NULL
and	NULL
age	NULL
,	NULL
further	NULL
study	NULL
is	NULL
indicated	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
ER/PR	NULL
positive	NULL
cells	NULL
are	NULL
subject	NULL
to	NULL
the	NULL
functional	NULL
heterogeneity	NULL
of	NULL
human	NULL
airway	NULL
mast	NULL
cells	NULL
and	NULL
whether	NULL
there	NULL
are	NULL
differences	NULL
in	NULL
functional	NULL
form	NULL
of	NULL
ER/PR	NULL
between	NULL
sexes	NULL
,	NULL
ages	NULL
,	NULL
or	NULL
between	NULL
asthmatic	NULL
subjects	NULL
whose	NULL
symptoms	NULL
remain	NULL
unchanged	NULL
and	NULL
those	NULL
who	NULL
experience	NULL
alteration	NULL
in	NULL
their	NULL
asthmatic	NULL
severity	NULL
in	NULL
relation	NULL
to	NULL
ovarian	NULL
hor-mones	NULL
.	NULL

We	NULL
expect	NULL
these	NULL
data	NULL
will	NULL
be	NULL
useful	NULL
in	NULL
understanding	NULL
the	NULL
effects	NULL
of	NULL
sex	NULL
hormones	NULL
in	NULL
airways	NULL
and	NULL
in	NULL
the	NULL
discovery	NULL
of	NULL
suitable	NULL
synthetic	NULL
steroid	NULL
derivatives	NULL
for	NULL
clinical	NULL
use	NULL
in	NULL
sex	NULL
hormone	NULL
related	NULL
inflammatory/autoimmune	NULL
diseases	NULL
including	NULL
nasal	NULL
allergy	NULL
and	NULL
asthma	NULL
.	NULL

This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
University	NULL
of	NULL
Ulster	NULL
Vice-Chancellor	NULL
's	NULL
Award	NULL
to	NULL
Xivjic	NULL
Zhao	NULL
.	NULL

bo	NULL
im	NULL
un	NULL
~-	NULL
a	NULL
co	NULL
©	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
1	NULL
co	NULL
19	NULL
20	NULL
2	NULL
wi	NULL
22	NULL
23	NULL
Busse	NULL
WW	NULL
.	NULL

Inflammation	NULL
in	NULL
asthma	NULL
:	NULL
the	NULL
cornerstone	NULL
of	NULL
the	NULL
discase	NULL
and	NULL
target	NULL
of	NULL
therapy	NULL
.	NULL

J	NULL
Allergy	NULL
Clin	NULL
Immunol	NULL
1998	NULL
;	NULL
102:517-22	NULL
.	NULL

Bingham	NULL
CO	NULL
,	NULL
Austen	NULL
KF	NULL
.	NULL

Mast-cell	NULL
responses	NULL
in	NULL
the	NULL
development	NULL
of	NULL
asthma	NULL
.	NULL

7	NULL
Allergy	NULL
Clin	NULL
Immunol	NULL
2000	NULL
;	NULL
105:8527-34	NULL
.	NULL

Larocca	NULL
LM	NULL
,	NULL
Maggiano	NULL
N	NULL
,	NULL
Capelli	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Immunopathol-ogy	NULL
of	NULL
nasal	NULL
polyps	NULL
:	NULL
an	NULL
immunohistochemical	NULL
approach	NULL
.	NULL

Ann	NULL
Allergy	NULL
1989	NULL
;	NULL
63:508-12	NULL
.	NULL

Stoop	NULL
AE	NULL
,	NULL
Hamclccrs	NULL
DM	NULL
,	NULL
v	NULL
Run	NULL
PE	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Lymphocytes	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
in	NULL
the	NULL
nasal	NULL
mucosa	NULL
of	NULL
patients	NULL
with	NULL
nasal	NULL
polyps	NULL
and	NULL
of	NULL
healthy	NULL
subjects	NULL
.	NULL

J	NULL
Allergy	NULL
Clin	NULL
Immunol	NULL
1989	NULL
;	NULL
84:734-41	NULL
.	NULL

Kawabori	NULL
S	NULL
,	NULL
Denburg	NULL
JA	NULL
,	NULL
Schwartz	NULL
LB	NULL
,	NULL
er	NULL
al	NULL
.	NULL

Histochemical	NULL
and	NULL
immunohistochemical	NULL
characteristics	NULL
of	NULL
mast	NULL
cells	NULL
in	NULL
nasal	NULL
polyps	NULL
.	NULL

Am	NULL
J	NULL
Respir	NULL
Cell	NULL
Mol	NULL
Biol	NULL
1992	NULL
;	NULL
6:37-43	NULL
.	NULL

Gibbs	NULL
CJ	NULL
,	NULL
Coutts	NULL
II	NULL
,	NULL
Lock	NULL
R	NULL
,	NULL
&	NULL
al	NULL
.	NULL

Premenstrual	NULL
exacerbation	NULL
of	NULL
asthma	NULL
.	NULL

Thorax	NULL
1984	NULL
;	NULL
39:833-6	NULL
.	NULL

Eliasson	NULL
O	NULL
,	NULL
Scherzer	NULL
HH	NULL
,	NULL
DeGraff	NULL
AC	NULL
.	NULL

Morbidity	NULL
in	NULL
asthma	NULL
in	NULL
relation	NULL
to	NULL
the	NULL
menstrual	NULL
cycle	NULL
.	NULL

J	NULL
AHergy	NULL
Clin	NULL
Immunol	NULL
1986	NULL
;	NULL
77:87-94	NULL
.	NULL

Benyon	NULL
HLC	NULL
,	NULL
Garbett	NULL
ND	NULL
,	NULL
Barnes	NULL
PJ	NULL
.	NULL

Severe	NULL
premenstrual	NULL
exacerbations	NULL
of	NULL
asthma	NULL
:	NULL
effect	NULL
of	NULL
intramuscular	NULL
progester-one	NULL
.	NULL

Lancet	NULL
1988	NULL
;	NULL
)	NULL
1:370-2	NULL
.	NULL

Troisi	NULL
RJ	NULL
,	NULL
Speizer	NULL
FE	NULL
,	NULL
Willet	NULL
WC	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Menopause	NULL
,	NULL
postmenopausal	NULL
estrogen	NULL
preparations	NULL
,	NULL
and	NULL
the	NULL
risk	NULL
of	NULL
adult-onset	NULL
asthma	NULL
.	NULL

A	NULL
prospective	NULL
cohort	NULL
study	NULL
.	NULL

Am	NULL
J	NULL
Respir	NULL
Crit	NULL
Care	NULL
Med	NULL
1995	NULL
;	NULL
152	NULL
:	NULL
1183-8	NULL
.	NULL

Skobeloff	NULL
EM	NULL
,	NULL
Spivey	NULL
WH	NULL
,	NULL
St	NULL
Clair	NULL
SS	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
influence	NULL
of	NULL
age	NULL
and	NULL
sex	NULL
on	NULL
asthma	NULL
admissions	NULL
.	NULL

AMA	NULL
1992	NULL
;	NULL
268	NULL
:	NULL
3437-40	NULL
.	NULL

Singh	NULL
AK	NULL
Cydulka	NULL
RK	NULL
,	NULL
Stahmer	NULL
SA	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Sex	NULL
differences	NULL
among	NULL
adults	NULL
presenting	NULL
to	NULL
the	NULL
emergency	NULL
department	NULL
with	NULL
acute	NULL
asthma	NULL
.	NULL

Multicenter	NULL
Asthma	NULL
Research	NULL
Collaboration	NULL
Investigators	NULL
.	NULL

Arch	NULL
Intern	NULL
Med	NULL
1999	NULL
;	NULL
159:1237-43	NULL
.	NULL

Barkman	NULL
RP	NULL
.	NULL

Sudden	NULL
death	NULL
in	NULL
asthma	NULL
.	NULL

Med	NULL
J	NULL
Aust	NULL
1981	NULL
;	NULL
1	NULL
:	NULL
316-7	NULL
.	NULL

Dong	NULL
Z	NULL
,	NULL
Zhao	NULL
XJ	NULL
,	NULL
Zhu	NULL
JG	NULL
.	NULL

Effect	NULL
of	NULL
estrogen	NULL
on	NULL
experimentally	NULL
induced	NULL
nasal	NULL
hypersensitivity	NULL
.	NULL

Chir	NULL
J	NULL
Ororhmolaryngol	NULL
1993	NULL
;	NULL
28:67-8	NULL
.	NULL

Moawad	NULL
AH	NULL
,	NULL
River	NULL
LP	NULL
,	NULL
Kilpatrick	NULL
SJ	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
estrogen	NULL
and	NULL
progesterone	NULL
on	NULL
beta-adrenergic	NULL
receptor	NULL
activity	NULL
in	NULL
rabbit	NULL
lung	NULL
tissue	NULL
.	NULL

Am	NULL
J	NULL
Obstet	NULL
Gynecol	NULL
1982	NULL
;	NULL
144:608-13	NULL
.	NULL

Cocchiara	NULL
R	NULL
,	NULL
Albeggiani	NULL
G	NULL
,	NULL
Di	NULL
Trapani	NULL
G	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Modulation	NULL
of	NULL
rat	NULL
peritoneal	NULL
mast	NULL
cell	NULL
and	NULL
human	NULL
basophil	NULL
histamine	NULL
release	NULL
by	NULL
estrogens	NULL
.	NULL

Int	NULL
Arch	NULL
Allergy	NULL
Appl	NULL
Immunol	NULL
1990	NULL
;	NULL
93:192-7	NULL
.	NULL

Mittman	NULL
RJ	NULL
,	NULL
Bernstein	NULL
DI	NULL
,	NULL
Steinberg	NULL
DR	NULL
,	NULL
e	NULL
al	NULL
.	NULL

Progesteronc-responsive	NULL
urticaria	NULL
and	NULL
cosinophilia	NULL
.	NULL

J	NULL
A/	NULL
lergy	NULL
Clin	NULL
Immunol	NULL
1989	NULL
;	NULL
84:304-10	NULL
.	NULL

Pang	NULL
X	NULL
,	NULL
CotreauBibbo	NULL
MM	NULL
,	NULL
Sant	NULL
GR	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Bladder	NULL
mast	NULL
cell	NULL
expression	NULL
of	NULL
high	NULL
affinity	NULL
oestrogen	NULL
receptors	NULL
in	NULL
patients	NULL
with	NULL
interstitial	NULL
cystitis	NULL
.	NULL

Br	NULL
J	NULL
Urol	NULL
1995	NULL
;	NULL
75:154-61	NULL
.	NULL

Cohen	NULL
JHM	NULL
,	NULL
Danel	NULL
L	NULL
,	NULL
Cordier	NULL
G.	NULL
Sex	NULL
steroid	NULL
receptors	NULL
in	NULL
peripheral	NULL
'T	NULL
cells	NULL
:	NULL
absence	NULL
of	NULL
androgen	NULL
receptors	NULL
and	NULL
restriction	NULL
of	NULL
estrogen	NULL
receptors	NULL
to	NULL
OKT8-positive	NULL
cells	NULL
.	NULL

7	NULL
Immunol	NULL
1983	NULL
;	NULL
131:2767-71	NULL
.	NULL

Gulshan	NULL
S	NULL
,	NULL
McCruden	NULL
AB	NULL
,	NULL
Stimson	NULL
WH	NULL
.	NULL

Oestrogen	NULL
receptors	NULL
in	NULL
macrophages	NULL
.	NULL

Scand	NULL
J	NULL
Immunol	NULL
1990	NULL
;	NULL
31:691-7	NULL
.	NULL

Castagnetta	NULL
L	NULL
,	NULL
Cutolo	NULL
M	NULL
,	NULL
Granata	NULL
OM	NULL
,	NULL
&	NULL
al	NULL
.	NULL

Endocrine	NULL
end-points	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Ann	NULL
NY	NULL
Acad	NULL
Sct	NULL
1999	NULL
;	NULL
876:180-92	NULL
.	NULL

Rider	NULL
V	NULL
,	NULL
Jones	NULL
SR	NULL
,	NULL
Evans	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Molecular	NULL
mechanisms	NULL
involved	NULL
in	NULL
the	NULL
estrogen-dependent	NULL
regulation	NULL
of	NULL
cal-cineurin	NULL
in	NULL
systemic	NULL
lupus	NULL
erythematosus	NULL
T	NULL
cells	NULL
Clin	NULL
Immunol	NULL
2000	NULL
;	NULL
95:124-34	NULL
.	NULL

Burry	NULL
RW	NULL
.	NULL

Specificity	NULL
controls	NULL
for	NULL
immunocytochemical	NULL
methods	NULL
.	NULL

J	NULL
Histochem	NULL
Cytochem	NULL
2000	NULL
;	NULL
48:163-6	NULL
.	NULL

Finotto	NULL
S	NULL
,	NULL
Dolovich	NULL
J	NULL
,	NULL
Denburg	NULL
JA	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Functional	NULL
heterogeneity	NULL
of	NULL
mast	NULL
cells	NULL
isolated	NULL
from	NULL
different	NULL
microcn-vironments	NULL
within	NULL
nasal	NULL
polyp	NULL
tissue	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
1994	NULL
;	NULL
95:343-50	NULL
.	NULL

Expression	NULL
of	NULL
oestrogen	NULL
and	NULL
progesterone	NULL
receptors	NULL
24	NULL
Mink	NULL
D	NULL
,	NULL
Hollaender	NULL
M	NULL
,	NULL
Von	NULL
Tongelen	NULL
B	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Demonstration	NULL
of	NULL
estrogen	NULL
and	NULL
progestronc	NULL
receptors	NULL
in	NULL
breast	NULL
cancers	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
:	NULL
different	NULL
results	NULL
with	NULL
enzyme-immunoassay	NULL
and	NULL
immunobhistochemical	NULL
methods	NULL
.	NULL

Eur	NULL
J	NULL
Gynaecol	NULL
Oncol	NULL
1995	NULL
;	NULL
16:81-91	NULL
.	NULL

25	NULL
Longphre	NULL
M	NULL
,	NULL
Zhang	NULL
LY	NULL
,	NULL
Harkema	NULL
JR	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Mast	NULL
cells	NULL
contribute	NULL
to	NULL
O3-induced	NULL
epithelial	NULL
damage	NULL
and	NULL
proliferation	NULL
in	NULL
nasal	NULL
and	NULL
bronchial	NULL
airways	NULL
of	NULL
mice	NULL
.	NULL

J	NULL
App	NULL
!	NULL

Physiol	NULL
1996	NULL
;	NULL
80:1322-30	NULL
.	NULL

26	NULL
Wodnar-Filipowicz	NULL
A	NULL
,	NULL
Heusser	NULL
CH	NULL
,	NULL
Moroni	NULL
C.	NULL
Production	NULL
of	NULL
the	NULL
hacmopoictic	NULL
growth	NULL
factors	NULL
GM-CSF	NULL
and	NULL
interleukin-3	NULL
by	NULL
mast	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
IgE	NULL
receptor-mediated	NULL
activation	NULL
.	NULL

Nature	NULL
1989	NULL
;	NULL
339:150-2.	NULL
www	NULL
.	NULL

thoraxjnl.com	NULL
211	NULL
27	NULL
Castells	NULL
M.	NULL
Update	NULL
on	NULL
mast	NULL
cells	NULL
and	NULL
mast	NULL
cell	NULL
precursors	NULL
and	NULL
hypersensitivity	NULL
responses	NULL
.	NULL

Alergy	NULL
Asthma	NULL
Proc	NULL
1997	NULL
;	NULL
18:287-92	NULL
.	NULL

28	NULL
Oskéritzian	NULL
C	NULL
,	NULL
Milon	NULL
G	NULL
,	NULL
Braquet	NULL
P	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Activated	NULL
mast	NULL
cells	NULL
release	NULL
biological	NULL
activities	NULL
able	NULL
to	NULL
support	NULL
cosinophil	NULL
production	NULL
from	NULL
mouse	NULL
hemopoietic	NULL
precursors	NULL
.	NULL

Cell	NULL
Immunol	NULL
1996	NULL
;	NULL
167:205-15	NULL
.	NULL

29	NULL
Rodgers	NULL
K	NULL
,	NULL
Xiong	NULL
S.	NULL
Contribution	NULL
of	NULL
mast	NULL
cell	NULL
mediators	NULL
to	NULL
alterations	NULL
in	NULL
macrophage	NULL
function	NULL
after	NULL
malathion	NULL
admin-istration	NULL
.	NULL

Fund	NULL
Appl	NULL
Toxicol	NULL
1996	NULL
;	NULL
33:100-8	NULL
.	NULL

30	NULL
King	NULL
A	NULL
,	NULL
Gardner	NULL
L	NULL
,	NULL
Loke	NULL
YW	NULL
.	NULL

Evaluation	NULL
of	NULL
estrogen	NULL
and	NULL
progesterone	NULL
receptor	NULL
expression	NULL
in	NULL
uterine	NULL
mucosal	NULL
lymphocytes	NULL
.	NULL

Human	NULL
Reprod	NULL
1996	NULL
;	NULL
11:1079-82	NULL
.	NULL

